A novel solution to cancer company’s market valuation woes; 'biology's century' and innovations in cancer treatment

Hundreds of biotechs have watched their valuations plummet. Now, one biotech investor is proposing a novel solution. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by   At the STAT Summit this Nov. 15-16, we're taking the discussion about drug prices away from pundits and listening to patients instead. Join David Mitchell, a cancer patient and founder of Patients for Affordable Drugs, and CF patient advocate Gunnar Esiason as they share their perspectives on ensuring patients can afford access to the treatments they need. Learn more here. STAT+: Novel solution to biotech's market valuation woes: Just give the cash back By Jason Mast and Adam Feuerstein PATRICK T. FALLON/AFP via Getty Images The request, made by Apeiron Investment of the biotech Sensei Biotherapeutics, is a bold response to an industry-wide problem. Read More Here's why we're not prepared for the next wave of biotech innovation By Matthew Herper From CRISPR to gene therapy, the biggest looming problem is that we will simply become lost and confused as to what works and what doesn't. Read More STAT+: Following your gut: How scientists are getting closer to linking the microbiome and chronic diseases By Isabella Cueto Adobe Several recent findings show how researchers are using new tools to push forward a field that has had a tumultuous few years. Read More Sponsored Insight by BlueSpark STAT E-Book: Detecting diseases earlier and treating them faster When it comes to health care, timing is everything. Whether it's detecting a case of Covid-19, or catching cancer in its earlier stages, the sooner doctors and patients know about a problem, the sooner they can act. In many cases, intervening earlier gives patients a better shot at a speedier recovery. The stories in this e-book highlight the promising new advances in disease detection and treatment, and hint at where the science is headed next. Download now. Opinion: Californians: To keep kids healthy, oppose sales of flavored nicotine products By Margaret Foti and Clifford Hudis Patrick T. FALLON/Getty On Tuesday, California voters should vote to ban flavored tobacco products including electronic nicotine delivery systems, which target kids. Read More STAT+: Microsoft's note-taking tool asks doctors to make a grand bargain: Share patient data, and get your life back By Casey Ross Hyacinth Empinado/STAT An AI-powered note-taking system from Microsoft and Nuance comes with a catch: Hospitals must share sensitive patient data to improve it. Read More STAT+: U.S. Supreme Court gives Amgen a boost by agreeing to review a closely watched patent case By Ed Silverman Adobe At issue is a long-running battle between Amgen and a pair of rivals over the market for injectable cholesterol treatments. Read More Opinion: Give Americans the right to save on health care By Jonathan Wolfson and Josh Archambault Adobe The Patient's Right to Save Act would ensure that insurers won't penalize people for saving money with a cash-based option. Read More Tuesday, November 8, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser